MeadowBrook Investment Advisors’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$61.8K Hold
611
0.05% 178
2026
Q1
$59.1K Hold
611
0.05% 173
2025
Q4
$64.9K Hold
611
0.06% 177
2025
Q3
$77.6K Hold
611
0.07% 167
2025
Q2
$74.9K Hold
611
0.07% 165
2025
Q1
$61.9K Hold
611
0.06% 164
2024
Q4
$56.4K Hold
611
0.05% 173
2024
Q3
$59K Hold
611
0.05% 165
2024
Q2
$52.4K Hold
611
0.05% 168
2024
Q1
$50.5K Hold
611
0.05% 171
2023
Q4
$40.8K Buy
+611
New +$39.6K 0.04% 178

Other funds holding EHC

MeadowBrook Investment Advisors's EHC Position: Q2 2026 in Review

MeadowBrook Investment Advisors held its Encompass Health (EHC) position steady in Q2 2026 at 611 shares worth $61.8K. The position accounts for 0.05% of the portfolio, ranked #178.

MeadowBrook Investment Advisors first reported a position in EHC in Q4 2023 and has held it in 11 quarters since. The position peaked at $77.6K in Q3 2025. 95 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • MeadowBrook Investment Advisors held 611 shares of Encompass Health worth $61.8K as of Q2 2026.
  • MeadowBrook Investment Advisors left its Encompass Health share count unchanged in Q2 2026.
  • Encompass Health made up 0.05% of MeadowBrook Investment Advisors's portfolio in Q2 2026, its #178 holding.
  • MeadowBrook Investment Advisors first reported a position in Encompass Health in Q4 2023 and has held it in 11 quarters since.
  • MeadowBrook Investment Advisors's Encompass Health position peaked at $77.6K in Q3 2025.
  • 95 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on MeadowBrook Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.